Based on the provided financial report articles, the title of the article is: "West Enclave Merger Corp. Reports Financial Results for the Quarter Ended March 31, 2026" Note that this is a quarterly report (Form 10-Q) filed with the Securities and Exchange Commission (SEC) by West Enclave Merger Corp., a company incorporated in the Cayman Islands.
West Enclave Merger Corp. filed its Form 10-Q for the quarter ended March 31, 2026. The company reported a significant increase in its cash and cash equivalents, from $[amount] as of December 31, 2025 to $[amount] as of March 31, 2026, primarily due to the issuance of [amount] of ordinary shares in connection with the exercise of the underwriters’ over-allotment option. The company also reported a net loss of $[amount] for the quarter, primarily due to the recognition of [amount] of expenses related to the business combination with [name of business]. As of March 31, 2026, the company had [amount] of total assets and [amount] of total liabilities, resulting in a stockholders’ deficit of [amount]. The company’s financial statements are presented in US dollars, and the company is a Cayman Islands exempted company with its principal executive offices located in Mexico City, Mexico.
Overview
We are a blank check company formed in the Cayman Islands on December 9, 2025 with the purpose of merging with or acquiring a business (a “Business Combination”). We raised $100 million through an initial public offering (IPO) on May 1, 2026, and an additional $15 million through the exercise of the over-allotment option, for a total of $116.15 million held in a trust account.
Our only activities so far have been organizational tasks, preparing for the IPO, and identifying potential target companies for a Business Combination. We have not generated any operating revenue yet and expect to incur significant costs in pursuing a Business Combination. There is no guarantee that our plans to complete a Business Combination will be successful.
Results of Operations
For the three months ended March 31, 2026, we had a net loss of $40,398, which consisted entirely of general and administrative costs. We have not engaged in any operations or generated any revenue to date. Our only income has been interest earned on the funds held in the trust account from the IPO.
Liquidity and Capital Resources
Prior to the IPO, our only source of funding was an initial purchase of shares by our sponsor and loans from the sponsor.
After the IPO and exercise of the over-allotment option, we have $116.15 million held in a trust account. We intend to use these funds, along with any interest earned, to complete a Business Combination. We may also need to obtain additional financing, either by issuing debt or equity, to complete a Business Combination.
We do not believe we will need to raise additional funds to cover our operating expenses prior to a Business Combination. However, our estimate of the costs to identify and evaluate a target, conduct due diligence, and negotiate a deal may be less than the actual amount required. In that case, we may need to obtain more financing.
Off-Balance Sheet Arrangements and Contractual Obligations
We have no off-balance sheet arrangements as of March 31, 2026. Our only significant contractual obligation is an agreement to pay $10,000 per month to an affiliate of our sponsor for office space, utilities, and administrative support.
We also have a Business Combination Marketing Agreement that requires us to pay a fee of 3.5% of the IPO gross proceeds to our advisor, EBC, upon completion of a Business Combination, with the ability to allocate up to half of that fee to other FINRA members who assist.
Critical Accounting Estimates
As of March 31, 2026, we did not have any critical accounting estimates to disclose.
